Imyitwarire mibi myinshi ya Paxlovid iroroheje. Ibiri isanzwe ni uburyohe budasanzwe (5% mu bushakashatsi) no kurwara impiswi (3%), byombi bisanzwe bishira mu minsi mike nyuma yo kurangiza iminsi itanu. Akaga gasaba gukora mbere ya dose ya mbere ni uburyo ibintu bifuzanya n'imiti, atari uburyohe.
\n\nTL;DR: Ibintu by'ingenzi bikwiye kwibukwa
\n- \n
- Dysgeusia (5%) n'impiswi (3%) ni byo bya mbere, byombi bikurikirana iminsi itanu aho kuba inyuma yayo. \n
- Abantu bake bahagaritse Paxlovid kubera imyitwarire mibi kuruta abahagaritse placebo, bityo uburyohe bubi ntibukwiye kuba impamvu yo guhagarika. \n
- Igice cya ritonavir gituma ibintu byinshi by'umuti bikoreshwa mu mubiri, ni cyo cyonyine cyakumvikana hano. \n
- Ha umunyamishinga w'imiti yawe yose uwushyira umwanditsi cyangwa farumasiye mbere ya dose ya mbere, atari nyuma y'uko ibimenyetso bitangiye. \n
- Kuvunja, kwangirika kw'uruhu, kuribwa cyangwa ibimenyetso by'ibibazo byihutirwa bya COVID-bireba mu gice gitandukanye burundu. \n
Imyitwarire myinshi mibi ya Paxlovid iroroheje, ihoraho kandi ntibayihagarika
\n\nImyitwarire mibi ya Paxlovid igaragara mu buryo bugaragara kandi bwiteguye. Dukurikije inyandiko y'umwanditsi wa FDA iherereye kuri DailyMed, dysgeusia (uburyohe budasanzwe cyangwa ubwa metallic) bugaragara kuri 5% y'abantu banywa imiti ugereranije n'ubugera kuri 1% ku placebo, hamwe impiswi kuri 3% ugereranije na 2% kuri placebo. Umutwe, kuruka, umuvuduko mwinshi w'amaraso n'ibisebe by'imitsi byuzuzanya urutonde.
\n\nUmubare ugaragaza ko mu bushakashatsi, 2% by'abantu bahagaritse Paxlovid kubera imyitwarire mibi, mu gihe 4% by'abantu bahagaritse placebo. Soma noneho. Urasabwa guhagarika igihe kuruta uwari unywa nta kintu na kimwe.
\n\nUgereranyije n'inyungu. Mu bushakashatsi bwikomeye bwashingiyeho uburenganzira, FDA yatangaje ko impfungu zigabanutseho 86% mu bitaro cyangwa urupfu rwa COVID-19 kugeza ku minsi 28, 0.9% ugereranije na 6.5%, mu bantu bakuze bafite ibyago byinshi kandi batikingije. Antivirals kuri virusi z'ubuhumekero zifite akamaro gakomeye, kimwe n'imyitwarire mibi ya Tamiflu.
\n\nImyitwarire mibi igomba gusuzumwa mbere ya dose ya mbere ntabwo ari uburyohe. Ni urutonde rw'imiti yawe
\n\nImiti ya Paxlovid ni akaga kamwe kavugwa kuri iyi page kandi gakomeye kandi kakumvikana burundu, kandi igihe cyo kukirinda kirashira mugihe wonywe igice cya mbere. Ritonavir, umuti wa kabiri mu gice, ni ingufu za CYP3A inhibitor. Ihari kugirango igabanye kugabanuka kwa nirmatrelvir, kandi igabanya kugabanuka kw'ibindi byinshi.
\n\nInyandiko irasobanura cyane ku byago, yirinda \"ibibazo by'ubuzima bubi, byihutirwa, cyangwa by'urupfu\" kubera ko ibintu by'umuti biyunze bikiri byinshi. Imiti isanzwe ifitanyijwe n'ibisubizo bikomeye ni ibinyobwa bya calcineurin nka tacrolimus na cyclosporine, na calcium channel blockers. Bimwe bifitanye na contraindication burundu: ergot derivatives, amiodarone, oral midazolam na triazolam.
\n\nRero, kora ibi none. Ha umunyamishinga cyangwa farumasiye buri rese, buri kintu cyo hejuru y'akazi, n'ikigongwe cyose wanyowe, St. John's wort irimo. Abantu basanzwe bagirira kwibagirwa kuvuga ku miti yo gukura n'ibicururiza nka Mucinex. Iyi ngingo ntabwo ari yo kontroli, kandi ntibishoboka.
\n\nNiba wiyumva neza kandi ukeneye iyi kontroli vuba, August's $39 online urgent care visit ikongeraho umuganga wemewe muri Leta Zunze Ubumwe za Amerika ushobora gusuzuma ibimenyetso byawe n'urutande rw'imiti yawe kandi ukemeza niba kuvura ari ngombwa. Umuganga ni we ufata icyemezo. Gusura ntibihereke